PSS Guide 2023
Pancreatic CancerFinancial Support

Drugs for Pancreatic Cancer

Find financial assistance programs available for pancreatic cancer drugs.

Abraxane (paclitaxel protein-bound particles; albumin-bound)

Drug company: Bristol Myers Squibb

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Abraxane:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Lynparza (olaparib) Capsules/Tablets

Drug company: AstraZeneca

AstraZeneca offers 2 financial assistance programs for patients who have been prescribed Lynparza:

Lynparza Co-pay Savings Program

AZ&Me Prescription Savings Program

Onivyde (irinotecan liposome injection)

Drug company: Ipsen

Ipsen Cares offers 2 financial assistance programs for patients using Onivyde:

Onivyde Copay Program

Ipsen Cares Patient Assistance Program

Tarceva (erlotinib) Tablets

Drug company: Genentech

Genentech Oncology offers 2 financial assistance program for patients using Tarceva:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Table. Drugs Prescribed for Pancreatic Cancer

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services

    Drug name (generic name)
  • Lynparza (olaparib) Capsules/Tablets
  • Drug company
  • AstraZeneca
  • Indication
  • Maintenance treatment of patients with metastatic pancreatic cancer and deleterious or suspected deleterious germline BRCA mutation, as detected by an FDA-approved test, in adults whose disease had not progressed after 16 weeks or more of platinum-based chemotherapy in the first-line setting
  • Patient support services
  • Lynparza Co-pay Savings Program

    AZ&Me Prescription Savings Program

Share this:

Last modified: March 9, 2023

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest
Other Interests